| scholarly article | Q13442814 |
| P50 | author | Yury M Morozov | Q57401071 |
| Yu-Yo Sun | Q88043534 | ||
| P2093 | author name string | Koji Abe | |
| Chia-Yi Kuan | |||
| Yikun Li | |||
| Pak H Chan | |||
| Dianer Yang | |||
| Pasko Rakic | |||
| Diana M Lindquist | |||
| R Scott Dunn | |||
| P2860 | cites work | Update of the stroke therapy academic industry roundtable preclinical recommendations | Q29615508 |
| Laser Doppler, speckle and related techniques for blood perfusion mapping and imaging | Q31033320 | ||
| Mouse model of in situ thromboembolic stroke and reperfusion | Q33294333 | ||
| A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy? | Q33938450 | ||
| Cerebral ischemia-hypoxia induces intravascular coagulation and autophagy | Q33998182 | ||
| The ischemic penumbra: correlates in imaging and implications for treatment of ischemic stroke. The Johann Jacob Wepfer award 2011. | Q34020415 | ||
| Glucocorticoid protection of oligodendrocytes against excitotoxin involving hypoxia-inducible factor-1alpha in a cell-type-specific manner. | Q34125992 | ||
| Ex vivo diffusion tensor imaging and neuropathological correlation in a murine model of hypoxia-ischemia-induced thrombotic stroke | Q34762997 | ||
| Cerebral microvessel responses to focal ischemia | Q35193869 | ||
| Preclinical stroke research--advantages and disadvantages of the most common rodent models of focal ischaemia | Q35589930 | ||
| Mannitol-facilitated perfusion staining with 2,3,5-triphenyltetrazolium chloride (TTC) for detection of experimental cerebral infarction and biochemical analysis | Q35707046 | ||
| Adjunctive and alternative approaches to current reperfusion therapy | Q35711810 | ||
| A Mouse Model of Hemorrhagic Transformation by Delayed Tissue Plasminogen Activator Administration After In Situ Thromboembolic Stroke | Q60589409 | ||
| Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitro | Q71576230 | ||
| Compartment- and context-specific changes in tissue-type plasminogen activator (tPA) activity following brain injury and pharmacological stimulation | Q83965053 | ||
| Administration of edaravone, a free radical scavenger, during t-PA infusion can enhance early recanalization in acute stroke patients--a preliminary study | Q85034903 | ||
| The two pathophysiologies of focal brain ischemia: implications for translational stroke research | Q36079309 | ||
| Antioxidant strategies in the treatment of stroke | Q36206823 | ||
| Plasminogen activator inhibitor-1 mitigates brain injury in a rat model of infection-sensitized neonatal hypoxia-ischemia. | Q36736945 | ||
| Therapeutic administration of plasminogen activator inhibitor-1 prevents hypoxic-ischemic brain injury in newborns. | Q37361862 | ||
| Can restoring incomplete microcirculatory reperfusion improve stroke outcome after thrombolysis? | Q38050626 | ||
| Protecting white matter from stroke injury. | Q38065070 | ||
| Safety, tolerability and pharmacokinetics of MCI-186 in patients with acute ischemic stroke: new formulation and dosing regimen | Q38153555 | ||
| Is misery perfusion still a predictor of stroke in symptomatic major cerebral artery disease? | Q39612584 | ||
| Revascularization end points in stroke interventional trials: recanalization versus reperfusion in IMS-I. | Q40381416 | ||
| Edaravone, a free radical scavenger, protects components of the neurovascular unit against oxidative stress in vitro | Q41837296 | ||
| Human recombinant tissue-plasminogen activator (alteplase): why not use the 'human' dose for stroke studies in rats? | Q41930720 | ||
| Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger | Q41968726 | ||
| Differences in clot preparation determine outcome of recombinant tissue plasminogen activator treatment in experimental thromboembolic stroke | Q42170505 | ||
| Evaluation of the PBR/TSPO radioligand [(18)F]DPA-714 in a rat model of focal cerebral ischemia | Q42414802 | ||
| Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. | Q43769073 | ||
| Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters | Q44418044 | ||
| Extension of ischemic therapeutic time window by a free radical scavenger, Edaravone, reperfused with tPA in rat brain | Q44895277 | ||
| Dissociation and protection of the neurovascular unit after thrombolysis and reperfusion in ischemic rat brain | Q46164241 | ||
| Translational stroke research of the combination of thrombolysis and antioxidant therapy | Q46170354 | ||
| Edaravone, a free radical scavenger, inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator | Q46190589 | ||
| The lipophilic multifunctional antioxidant edaravone (radicut) improves behavior following embolic strokes in rabbits: a combination therapy study with tissue plasminogen activator | Q46318985 | ||
| The novel antioxidant edaravone: from bench to bedside | Q46591722 | ||
| Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain | Q46706351 | ||
| Assessing reperfusion and recanalization as markers of clinical outcomes after intravenous thrombolysis in the echoplanar imaging thrombolytic evaluation trial (EPITHET). | Q47701499 | ||
| Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions. | Q48162562 | ||
| Capillary patency after transient middle cerebral artery occlusion of 2 h duration | Q48365225 | ||
| Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke | Q48593375 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | edaravone | Q335099 |
| thrombotic stroke | Q107538760 | ||
| P304 | page(s) | e98807 | |
| P577 | publication date | 2014-06-09 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Synergy of combined tPA-edaravone therapy in experimental thrombotic stroke | |
| P478 | volume | 9 |
| Q41866520 | A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia |
| Q90750947 | A murine photothrombotic stroke model with an increased fibrin content and improved responses to tPA-lytic treatment |
| Q28389192 | Alteration of SLP2-like immunolabeling in mitochondria signifies early cellular damage in developing and adult mouse brain |
| Q38283295 | Anti-tissue plasminogen activator (tPA) as an effective therapy of neonatal hypoxia-ischemia with and without inflammation |
| Q39169261 | Diabetic aggravation of stroke and animal models. |
| Q64080333 | IMM-H004 Protects against Cerebral Ischemia Injury and Cardiopulmonary Complications via CKLF1 Mediated Inflammation Pathway in Adult and Aged Rats |
| Q30968894 | Prophylactic Edaravone Prevents Transient Hypoxic-Ischemic Brain Injury: Implications for Perioperative Neuroprotection |
| Q35516501 | Protein kinase C-dependent growth-associated protein 43 phosphorylation regulates gephyrin aggregation at developing GABAergic synapses |
| Q47414741 | Sickle Mice Are Sensitive to Hypoxia/Ischemia-Induced Stroke but Respond to Tissue-Type Plasminogen Activator Treatment |
| Q37394086 | Stereotactic Administration of Edaravone Ameliorates Collagenase-Induced Intracerebral Hemorrhage in Rat |
| Q40445057 | Towards reperfusion-centric preclinical stroke research: outside the box of "reperfusion injury" |
| Q28078744 | Update on Inflammatory Biomarkers and Treatments in Ischemic Stroke |
| Q39031301 | Vascular inter-regulation of inflammation: molecular and cellular targets for CNS therapy |
Search more.